Prescribing thiamine to inpatients with alcohol use disorders

How well are we doing?

Elie Isenberg-Grzeda, Brenda Chabon, Stephen E. Nicolson

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

Objectives: Thiamine deficiency is a potentially dangerous sequela of alcohol use disorders (AUDs). European andBritish guidelines recommend administering high-dose parenteral thiamine 3 times daily to avoid consequences of thiamine deficiency such as Wernicke-Korsakoff syndrome (WKS), and suggest that traditional thiamine dosages are likely inadequate. Research into thiamine and WKS has lagged in the United States, and to date, no study has examined how thiamine is prescribed to inpatients with AUD in an American hospital. Methods: Thiamine prescribing data (amount, route, and frequency schedule) were collected for inpatients at a large, American, teaching hospital, who were referred to the addiction psychiatry service for AUD. Data were analyzed using Statistical Product and Service Solutions. Results: A total of 217 inpatients with AUD were included. A substantial percentage of them were not prescribed thiamine. Of those who were prescribed thiamine, nearly all were prescribed oral thiamine at traditional dosages, including high-risk patients. Conclusions: This is the first study to report on the prescribing of thiamine to inpatients with AUD at an American teaching hospital. It serves to confirm what many already suspected: that more education is needed to improve the diagnostic challenges ofWKS, the detection of risk factors for WKS, and the adequate dosing of thiamine for prevention and treatment of WKS.

Original languageEnglish (US)
Pages (from-to)1-5
Number of pages5
JournalJournal of Addiction Medicine
Volume8
Issue number1
DOIs
StatePublished - 2014

Fingerprint

Thiamine
Inpatients
Alcohols
Korsakoff Syndrome
Thiamine Deficiency
Teaching Hospitals
Psychiatry
Appointments and Schedules
Guidelines
Education

Keywords

  • Alcohol-related disorders
  • Korsakoff syndrome
  • Thiamine
  • Wernicke encephalopathy

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Pharmacology (medical)

Cite this

Prescribing thiamine to inpatients with alcohol use disorders : How well are we doing? / Isenberg-Grzeda, Elie; Chabon, Brenda; Nicolson, Stephen E.

In: Journal of Addiction Medicine, Vol. 8, No. 1, 2014, p. 1-5.

Research output: Contribution to journalArticle

Isenberg-Grzeda, Elie ; Chabon, Brenda ; Nicolson, Stephen E. / Prescribing thiamine to inpatients with alcohol use disorders : How well are we doing?. In: Journal of Addiction Medicine. 2014 ; Vol. 8, No. 1. pp. 1-5.
@article{d424f594d8d44b2aa0534de70e92463d,
title = "Prescribing thiamine to inpatients with alcohol use disorders: How well are we doing?",
abstract = "Objectives: Thiamine deficiency is a potentially dangerous sequela of alcohol use disorders (AUDs). European andBritish guidelines recommend administering high-dose parenteral thiamine 3 times daily to avoid consequences of thiamine deficiency such as Wernicke-Korsakoff syndrome (WKS), and suggest that traditional thiamine dosages are likely inadequate. Research into thiamine and WKS has lagged in the United States, and to date, no study has examined how thiamine is prescribed to inpatients with AUD in an American hospital. Methods: Thiamine prescribing data (amount, route, and frequency schedule) were collected for inpatients at a large, American, teaching hospital, who were referred to the addiction psychiatry service for AUD. Data were analyzed using Statistical Product and Service Solutions. Results: A total of 217 inpatients with AUD were included. A substantial percentage of them were not prescribed thiamine. Of those who were prescribed thiamine, nearly all were prescribed oral thiamine at traditional dosages, including high-risk patients. Conclusions: This is the first study to report on the prescribing of thiamine to inpatients with AUD at an American teaching hospital. It serves to confirm what many already suspected: that more education is needed to improve the diagnostic challenges ofWKS, the detection of risk factors for WKS, and the adequate dosing of thiamine for prevention and treatment of WKS.",
keywords = "Alcohol-related disorders, Korsakoff syndrome, Thiamine, Wernicke encephalopathy",
author = "Elie Isenberg-Grzeda and Brenda Chabon and Nicolson, {Stephen E.}",
year = "2014",
doi = "10.1097/01.ADM.0000435320.72857.c8",
language = "English (US)",
volume = "8",
pages = "1--5",
journal = "Journal of Addiction Medicine",
issn = "1932-0620",
publisher = "Lippincott Williams and Wilkins",
number = "1",

}

TY - JOUR

T1 - Prescribing thiamine to inpatients with alcohol use disorders

T2 - How well are we doing?

AU - Isenberg-Grzeda, Elie

AU - Chabon, Brenda

AU - Nicolson, Stephen E.

PY - 2014

Y1 - 2014

N2 - Objectives: Thiamine deficiency is a potentially dangerous sequela of alcohol use disorders (AUDs). European andBritish guidelines recommend administering high-dose parenteral thiamine 3 times daily to avoid consequences of thiamine deficiency such as Wernicke-Korsakoff syndrome (WKS), and suggest that traditional thiamine dosages are likely inadequate. Research into thiamine and WKS has lagged in the United States, and to date, no study has examined how thiamine is prescribed to inpatients with AUD in an American hospital. Methods: Thiamine prescribing data (amount, route, and frequency schedule) were collected for inpatients at a large, American, teaching hospital, who were referred to the addiction psychiatry service for AUD. Data were analyzed using Statistical Product and Service Solutions. Results: A total of 217 inpatients with AUD were included. A substantial percentage of them were not prescribed thiamine. Of those who were prescribed thiamine, nearly all were prescribed oral thiamine at traditional dosages, including high-risk patients. Conclusions: This is the first study to report on the prescribing of thiamine to inpatients with AUD at an American teaching hospital. It serves to confirm what many already suspected: that more education is needed to improve the diagnostic challenges ofWKS, the detection of risk factors for WKS, and the adequate dosing of thiamine for prevention and treatment of WKS.

AB - Objectives: Thiamine deficiency is a potentially dangerous sequela of alcohol use disorders (AUDs). European andBritish guidelines recommend administering high-dose parenteral thiamine 3 times daily to avoid consequences of thiamine deficiency such as Wernicke-Korsakoff syndrome (WKS), and suggest that traditional thiamine dosages are likely inadequate. Research into thiamine and WKS has lagged in the United States, and to date, no study has examined how thiamine is prescribed to inpatients with AUD in an American hospital. Methods: Thiamine prescribing data (amount, route, and frequency schedule) were collected for inpatients at a large, American, teaching hospital, who were referred to the addiction psychiatry service for AUD. Data were analyzed using Statistical Product and Service Solutions. Results: A total of 217 inpatients with AUD were included. A substantial percentage of them were not prescribed thiamine. Of those who were prescribed thiamine, nearly all were prescribed oral thiamine at traditional dosages, including high-risk patients. Conclusions: This is the first study to report on the prescribing of thiamine to inpatients with AUD at an American teaching hospital. It serves to confirm what many already suspected: that more education is needed to improve the diagnostic challenges ofWKS, the detection of risk factors for WKS, and the adequate dosing of thiamine for prevention and treatment of WKS.

KW - Alcohol-related disorders

KW - Korsakoff syndrome

KW - Thiamine

KW - Wernicke encephalopathy

UR - http://www.scopus.com/inward/record.url?scp=84898730846&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84898730846&partnerID=8YFLogxK

U2 - 10.1097/01.ADM.0000435320.72857.c8

DO - 10.1097/01.ADM.0000435320.72857.c8

M3 - Article

VL - 8

SP - 1

EP - 5

JO - Journal of Addiction Medicine

JF - Journal of Addiction Medicine

SN - 1932-0620

IS - 1

ER -